Opinion · 4 Mar 2025
Mini reviewPublished 29 Mar 2024
Drug development Against Amebiasis
Department of Pharmacology, Colorado State University, U.S.A
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Amebiasis, caused by the protozoan parasite Entamoeba histolytica, remains a significant global health challenge, particularly in developing countries with poor sanitation infrastructure. Current treatment options primarily rely on Nitroimidazole drugs such as Metronidazole and Tinidazole, albeit concerns regarding drug resistance and adverse effects persist. Consequently, there is an urgent need for novel therapeutic interventions against this devastating disease. This abstract reviews recent advancements in drug development targeting E. histolytica. Nitazoxanide, with its ability to disrupt the pyruvate-ferredoxin oxidoreductase enzyme in the parasite, has emerged as a promising alternative. Additionally, aminoglycoside antibiotics like Paromomycin, which inhibit protein synthesis in the parasite, have demonstrated efficacy in combination therapy.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 30 Jan 2025
The Role of Pharmacogenomics in Modern Drug Development
Commentary · 27 Sep 2024
Integrating High-Throughput Screening with Genomic and Proteomic Approaches in Drug Development
Perspective · 25 Jun 2024
Phase I Metabolism and Drug Development: Challenges and Innovations
Commentary · 25 Jun 2024
The Role of Toxicokinetics in Drug Development and Safety Assessment
More from this journal
The newest in World Journal of Pharmacology and Toxicology.
Research article · 17 Apr 2025
Investigating the Potential for Memory Enhancer Activity in Wistar Rats Using Extracts from Chenopodialum album Leaves
Editorial · 28 Mar 2025
Role of Reactive Oxygen Species in Experimental Models of Hepatorenal Toxicity
Editorial · 28 Mar 2025
Toxicological Evaluation of Novel Protein-Based Food Additives
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalWorld Journal of Pharmacology and Toxicology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Dexter Petri”
